Workup for Multiple Sclerosis
Core Diagnostic Approach
The workup for multiple sclerosis requires demonstrating dissemination of inflammatory-demyelinating lesions in both space and time through MRI imaging, combined with clinical evidence and exclusion of alternative diagnoses. 1, 2
Clinical Assessment
Essential Clinical Evaluation
Document objective neurological signs on examination - symptoms alone are insufficient for diagnosis 3, 2
Look for typical presentations including:
Define attacks properly: neurological disturbance lasting ≥24 hours, with at least 30 days between separate attacks, excluding pseudoattacks from fever or infection 2
Age Considerations
- Criteria apply best to patients aged 18-50 years 1, 2
- In patients >50 years or with vascular risk factors, require more stringent criteria (e.g., higher number of periventricular lesions abutting lateral ventricles) 1
- In pediatric cases <11 years, look for at least one T1 hypointense lesion ("black hole") and one periventricular lesion to distinguish MS from monophasic demyelination 1, 2
MRI Imaging Protocol
Brain MRI (Essential)
Perform brain MRI with gadolinium contrast on minimum 1.5T scanner 1, 2
Required sequences include:
- Axial T2-weighted and T2-FLAIR sequences 1, 2
- Axial T1-weighted pre- and post-gadolinium sequences 1, 2
- Sagittal 2D or isotropic 3D T2-FLAIR sequences 2
- Use 3D acquisitions or 2D with 3-mm thick slices with no gap 1
Spinal Cord MRI (Mandatory)
Obtain spinal cord MRI even without spinal symptoms - 30-40% of clinically isolated syndrome patients have asymptomatic cord lesions 2
Protocol includes:
- Sagittal dual-echo sequences 2
- Sagittal STIR sequences 2
- Contrast-enhanced T1-weighted spin-echo sequences 2
- Image cervical, thoracic, and lumbar spine as MS lesions can occur anywhere in CNS 1
MRI Diagnostic Criteria
Dissemination in space requires lesions in ≥2 of 4 characteristic CNS regions 1, 2:
- Periventricular (abutting lateral ventricles)
- Cortical/juxtacortical
- Infratentorial
- Spinal cord
Dissemination in time is demonstrated by 2:
- Simultaneous gadolinium-enhancing and non-enhancing lesions on single MRI, OR
- New T2 or enhancing lesions on follow-up imaging (minimum 3 months after clinical event) 1
Cerebrospinal Fluid Analysis
Perform lumbar puncture when 3, 2:
- Imaging criteria are not fully satisfied
- Clinical presentation is atypical
- Progressive onset without relapses (primary progressive MS)
- Need to exclude alternative diagnoses
Key CSF findings include:
- Oligoclonal bands (evidence of intrathecal IgG synthesis) 3, 2
- Elevated IgG index 2
- Albumino-cytological dissociation 2
For primary progressive MS specifically: abnormal CSF with evidence of inflammation is essential, plus dissemination in space (MRI or abnormal VEP) and time (MRI or continued progression for 1 year) 1
Laboratory Studies to Exclude Mimics
Essential blood tests 2:
- Complete blood count and comprehensive metabolic panel
- Vitamin B12 level 7
- Anti-aquaporin-4 (AQP4) antibodies to exclude neuromyelitis optica spectrum disorder 3, 2
- Consider anti-MOG antibodies in atypical cases 1
Additional tests when clinically indicated 3:
- Antinuclear antibody (ANA) and antiphospholipid antibodies
- Lyme serology in endemic areas 7
- Syphilis serology 7
- HTLV-1 testing 3
Additional Paraclinical Tests
Visual Evoked Potentials (VEP)
- Suspected optic nerve involvement
- MRI access is limited
- Atypical presentations requiring additional evidence
- Primary progressive MS to demonstrate dissemination in space 1
Optic Nerve Imaging
Fat-suppressed MRI of optic nerves should be considered in atypical cases to rule out alternative diagnoses 1
Critical Diagnostic Pitfalls
Red Flags Requiring Alternative Diagnosis Consideration
- Bilateral sudden hearing loss (not typical of MS) 3
- Sudden onset focal symptoms with headache suggesting stroke 3
- Age-related periventricular capping on T2-weighted images 1
- Ischemic lesion patterns 1
- Peculiar patterns of contrast enhancement 1
Differential Diagnoses to Exclude
- Neuromyelitis optica spectrum disorder (check AQP4 antibodies)
- Cerebrovascular disease (especially in patients >50 years or with vascular risk factors) 3
- Infectious diseases (Lyme disease, syphilis, HTLV-1) 3, 7
- Inflammatory conditions (sarcoidosis, systemic lupus erythematosus, Sjögren's syndrome) 7
- Vitamin B12 deficiency 7
- Spinal cord compression 7
Essential Diagnostic Principle
No diagnosis of MS can be made if there is a better explanation for the clinical and paraclinical abnormalities 1, 3
Specialist Referral
Diagnosis must be made by a specialist familiar with MS, its differential diagnoses, and interpretation of paraclinical assessments 3, 2 - neurology consultation is essential for definitive diagnosis and treatment initiation 3